-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $330

Benzinga·07/23/2026 17:55:46
语音播报
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $324 to $330.